Eton posts record Q3 revenue, raises 2026 guidance, advances rare disease pipelineNov 5PartnershipEton Pharmaceuticals, Inc.Updated
Vanderbilt trial tests intrathecal cytarabine for ICANS after CAR T; Gilead is collaboratorOct 2Trial updatecytarabineGilead Sciences
Eton Pharmaceuticals posts 99% revenue growth, raises 2026 guidance to over $145 millionAug 13Quarterly updateEton Pharmaceuticals, Inc.
Vanderbilt registers Phase 2 Lazarus trial testing IT therapy to prevent ICANS after CAR TAug 13Trial updateGilead Sciences
Eton Pharmaceuticals submits FDA supplement to expand KHINDIVI to younger childrenJul 29Regulatory decisionEton Pharmaceuticals, Inc.hydrocortisone